No Photo Available

Last Update

This profile was last updated on .

Is this you? Claim your profile.

Wrong David Hallal?

Mr. David L. Hallal

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

ALEXON GROUP PLC

Chief Executive Officer

Alexion Pharmaceuticals Inc

Affiliations

Board Member
PhRMA companies

Board Member
Biotechnology Industry Organization

Education

BA

University of New Hampshire

Web References (76 Total References)


Separately, Alexion reports that its ...

cureconnect.org [cached]

Separately, Alexion reports that its board of directors has appointed David L. Hallal as the Company's chief executive officer, effective April 1. Mr. Hallal currently serves as Alexion's chief operating officer and is a director.


David ...

phrma.org [cached]

David Hallal

Chief Executive Officer Alexion Pharmaceuticals, Inc.
Read More


Leadership: Management & Board Directors | Alexion, Rare Disease Leader

alexion.com [cached]

David Hallal, Chief Executive Officer

...
David Hallal, Alexion - Chief Executive Officer
David Hallal is Chief Executive Officer of Alexion and a member of the company's Board of Directors..
Mr. Hallal was appointed Alexion's second CEO in its 24-year history in April 2015, leading the company to expand its position as the global leader in rare diseases through an important acquisition and the approvals and launches of two highly innovative products. Prior to becoming CEO, Mr. Hallal was Chief Operating Officer, leading strategic enterprise-wide initiatives that focused on diverse aspects of Alexion's business, including the expansion of the company's research and development pipeline and manufacturing operations. Previously, Mr. Hallal was Alexion's first Chief Commercial Officer.
Mr. Hallal joined Alexion in 2006 to build the company's commercial operations and he led the successful introduction of Soliris ® (eculizumab), the company's first product for two ultra-rare diseases. He played a principal role in leading many significant growth initiatives including the development of Alexion's 50-country operating platform. In addition to his leadership of all global commercial operations, Mr. Hallal has been responsible for country operations in each of Alexion's affiliates in Europe/Middle East/Africa (EMEA), Japan, Australasia, and Latin America.
Mr. Hallal has more than 25 years of experience in the biopharmaceutical industry. Before joining Alexion, he advanced through positions of increasing responsibility in sales, marketing and management at Amgen, Biogen, and OSI Eyetech directing product launches in the areas of hematology, oncology, nephrology and immunology.
Mr. Hallal is a member of the Board of Directors of the Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization. He holds a Bachelor of Arts degree from the University of New Hampshire.
...
David Hallal, Chief Executive Officer
David Hallal is Chief Executive Officer of Alexion. Prior to becoming CEO, Mr. Hallal was Chief Operating Officer, leading strategic enterprise-wide initiatives that focused on diverse aspects of Alexion's operations. He also has served on all key management decision-making committees, and in September 2014 was elected to the Company's Board of Directors. Previously, Mr. Hallal was Alexion's first Chief Commercial Officer.
Mr. Hallal joined Alexion in 2006 to launch the company's commercial operations. He played a principal role in leading many of the company's major growth initiatives and led the highly successful introductions of Soliris® (eculizumab) for both PNH and aHUS, while also building Alexion's 50-country operating platform. In addition to his leadership of all commercial operations globally, Mr. Hallal has been responsible for country operations in each of Alexion's affiliates in Europe/Middle East/Africa (EMEA), Japan, Australasia, and Latin America.
Mr. Hallal has more than 25 years of experience in the biopharmaceutical industry. Before joining Alexon, he held commercial leadership positions at OSI Eyetech, Biogen Idec and Amgen where he was involved in multiple blockbuster product launches in the areas of hematology, oncology, nephrology and immunology. Mr. Hallal holds a BA from the University of New Hampshire.


Alexion Pharmaceuticals, Inc. - Management

ir.alexionpharm.com [cached]

David Hallal Chief Executive Officer

...
David Hallal
David Hallal is Chief Executive Officer of Alexion. Prior to becoming CEO, Mr. Hallal was Chief Operating Officer, leading strategic enterprise-wide initiatives that focused on diverse aspects of Alexion's operations. He also has served on all key management decision-making committees, and in September 2014 was elected to the Company's Board of Directors. Previously, Mr. Hallal was Alexion's first Chief Commercial Officer.
Mr. Hallal joined Alexion in 2006 to launch the company's commercial operations. He played a principal role in leading many of the company's major growth initiatives and led the highly successful introductions of Soliris® (eculizumab) for both PNH and aHUS, while also building Alexion's 50-country operating platform. In addition to his leadership of all commercial operations globally, Mr. Hallal has been responsible for country operations in each of Alexion's affiliates in Europe/Middle East/Africa (EMEA), Japan, Australasia, and Latin America.
Mr. Hallal has more than 25 years of experience in the biopharmaceutical industry. Before joining Alexion, he held commercial leadership positions at OSI Eyetech, Biogen Idec and Amgen where he was involved in multiple blockbuster product launches in the areas of hematology, oncology, nephrology and immunology. Mr. Hallal holds a BA from the University of New Hampshire.


David Hallal has been ...

cureconnect.org [cached]

David Hallal has been promoted to the new position of chief operating officer at Alexion Pharmaceuticals.

Similar Profiles

Other People with this Name

Other people with the name Hallal

Charles Hallal
Marsh & McLennan Companies

Alexcia Hallal
Premier Strata

Ali Hallal
American University of Beirut

Ahmad Hallal
SABIS International Charter School

Suzan Hallal
Johnson & Johnson

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory